[1]
Rodriguez Orengo, A. et al. 2026. Histopathologic Insights and Treatment Outcomes in PD-1 and PDL-1 Cutaneous Immune-Related Adverse Events: A Case Series. International Journal of Medical Students. 14, 1 (Mar. 2026), 19–23. DOI:https://doi.org/10.5195/ijms.2026.3588.